Community hub
Recent from talks
Knowledge base stats:
Talk channels stats:
Members stats:
Robert MacLaren
Robert E. MacLaren (born 14 November 1966) is a British ophthalmologist who has led pioneering work in the treatment of blindness caused by diseases of the retina. He is Professor of Ophthalmology at the University of Oxford and Honorary Professor of Ophthalmology at the UCL Institute of Ophthalmology. He is a Consultant Ophthalmologist at the Oxford Eye Hospital. He is also an Honorary Consultant Vitreo-retinal Surgeon at the Moorfields Eye Hospital. MacLaren is an NIHR Senior Investigator, or lead researcher, for the speciality of Ophthalmology. In addition, he is a member of the research committee of Euretina: the European Society of Retina specialists, Fellow of Merton College, in Oxford and a Fellow of the Higher Education Academy.
Robert MacLaren was born on 14 November 1966, at Epsom in Surrey. His father was a photographer, which prompted an early interest in optics. MacLaren was educated and trained at the University of Edinburgh Medical School, from 1985 to 1990, where he graduated with a Bachelor of Medicine and a Bachelor of Surgery. MacLaren then earned an academic doctorate, between 1992 and 1995, at the University of Oxford. The doctorate was for his work on optic-nerve regeneration.[citation needed]
MacLaren was appointed Professor of Ophthalmology at the University of Oxford in March 2009. In February of the same year, he was made Honorary Professor of Ophthalmology at the UCL Institute of Ophthalmology. He has been a Fellow of the Royal College of Ophthalmologists (FRCOphth) since June 2003.
MacLaren is a professor in the Nuffield Laboratory of Ophthalmology (NLO), the academic ophthalmology outstation of Oxford University's Nuffield Department of Clinical Neurosciences, which is part of the Medical Sciences Division and based in the John Radcliffe Hospital.
MacLaren is described as 'one of the stars' of the developing inter-disciplinary field of ophthalmic translational medicine (TM). This combines practical skills in eye surgery with clinical academic application in research, to investigate the diseases of the eye 'from bench to bedside': aiming to improve patient outcomes, at least by arresting or slowing the progress of a disease, or – ideally – by reversing the effects, partially or totally. Once the processes of the diseases are understood, new surgical technologies are furthering the options for a surgical solution and new ophthalmic technologies have created a variety of implants, such as electronic retinal devices for prosthesis. Furthermore, the enhanced precision of surgery allows additional interventions, with the application of gene therapy and stem-cell therapy to retinal dystrophies (inherited conditions).
MacLaren has been a Consultant Ophthalmic Surgeon for the Oxford University Hospitals NHS Foundation Trust (OUH) since March 2009. His surgical work is based largely at the Oxford Eye Hospital and the Nuffield Laboratory of Ophthalmology [NLO], both located within the John Radcliffe Hospital, on Headington Hill in Oxford. He has also been Honorary Consultant Vitreoretinal Surgeon at Moorfields Eye Hospital NHS Foundation Trust, in London, since May 2006.
He has been a Fellow of the Royal College of Surgeons of Edinburgh (RCSEd) since July 1998 and was awarded their annual King James IV Professorship in 2007.
He is one of the first surgeons in the world to have made a successful retinal implant for visual prosthesis, sometimes described as creating: a 'bionic eye'. He is also a pioneer in robot-assisted surgery for ophthalmic operations. Key events of his work at the Moorfields and John Radcliffe hospitals include:
Hub AI
Robert MacLaren AI simulator
(@Robert MacLaren_simulator)
Robert MacLaren
Robert E. MacLaren (born 14 November 1966) is a British ophthalmologist who has led pioneering work in the treatment of blindness caused by diseases of the retina. He is Professor of Ophthalmology at the University of Oxford and Honorary Professor of Ophthalmology at the UCL Institute of Ophthalmology. He is a Consultant Ophthalmologist at the Oxford Eye Hospital. He is also an Honorary Consultant Vitreo-retinal Surgeon at the Moorfields Eye Hospital. MacLaren is an NIHR Senior Investigator, or lead researcher, for the speciality of Ophthalmology. In addition, he is a member of the research committee of Euretina: the European Society of Retina specialists, Fellow of Merton College, in Oxford and a Fellow of the Higher Education Academy.
Robert MacLaren was born on 14 November 1966, at Epsom in Surrey. His father was a photographer, which prompted an early interest in optics. MacLaren was educated and trained at the University of Edinburgh Medical School, from 1985 to 1990, where he graduated with a Bachelor of Medicine and a Bachelor of Surgery. MacLaren then earned an academic doctorate, between 1992 and 1995, at the University of Oxford. The doctorate was for his work on optic-nerve regeneration.[citation needed]
MacLaren was appointed Professor of Ophthalmology at the University of Oxford in March 2009. In February of the same year, he was made Honorary Professor of Ophthalmology at the UCL Institute of Ophthalmology. He has been a Fellow of the Royal College of Ophthalmologists (FRCOphth) since June 2003.
MacLaren is a professor in the Nuffield Laboratory of Ophthalmology (NLO), the academic ophthalmology outstation of Oxford University's Nuffield Department of Clinical Neurosciences, which is part of the Medical Sciences Division and based in the John Radcliffe Hospital.
MacLaren is described as 'one of the stars' of the developing inter-disciplinary field of ophthalmic translational medicine (TM). This combines practical skills in eye surgery with clinical academic application in research, to investigate the diseases of the eye 'from bench to bedside': aiming to improve patient outcomes, at least by arresting or slowing the progress of a disease, or – ideally – by reversing the effects, partially or totally. Once the processes of the diseases are understood, new surgical technologies are furthering the options for a surgical solution and new ophthalmic technologies have created a variety of implants, such as electronic retinal devices for prosthesis. Furthermore, the enhanced precision of surgery allows additional interventions, with the application of gene therapy and stem-cell therapy to retinal dystrophies (inherited conditions).
MacLaren has been a Consultant Ophthalmic Surgeon for the Oxford University Hospitals NHS Foundation Trust (OUH) since March 2009. His surgical work is based largely at the Oxford Eye Hospital and the Nuffield Laboratory of Ophthalmology [NLO], both located within the John Radcliffe Hospital, on Headington Hill in Oxford. He has also been Honorary Consultant Vitreoretinal Surgeon at Moorfields Eye Hospital NHS Foundation Trust, in London, since May 2006.
He has been a Fellow of the Royal College of Surgeons of Edinburgh (RCSEd) since July 1998 and was awarded their annual King James IV Professorship in 2007.
He is one of the first surgeons in the world to have made a successful retinal implant for visual prosthesis, sometimes described as creating: a 'bionic eye'. He is also a pioneer in robot-assisted surgery for ophthalmic operations. Key events of his work at the Moorfields and John Radcliffe hospitals include: